NASHVILLE, Tenn., Nov. 2, 2015 /PRNewswire/ -- In response to the growing number of international news stories about antibiotic resistance and bacterial superbugs, Diatherix Laboratories and Thermo Fisher Scientific will convene ABX CROSSROADS, a national symposium to explore the clinical, financial and operational challenges facing healthcare providers in the "post-antibiotic era."
ABX CROSSROADS will assemble a national audience of pharmacists, hospitalists, infection control specialists and healthcare administrators on Nov. 6, at the Hutton Hotel in Nashville. The day-long symposium is designed to help participants share knowledge, learn best practices and advance the national dialogue on antimicrobial stewardship.
"The alarming speed of the antibiotic resistance crisis is clearly outpacing conventional thinking," said Chris Linthwaite, president of genetic sciences at Thermo Fisher Scientific. "Only through a focused, national dialogue that is supported by innovative thinking and collaboration will we be able to explore new strategies to address this global threat to human health."
James Michael Keegan, M.D., Principal and Service Line Leader for Antibiotic Stewardship at Pershing Yoakley & Associates, will serve as moderator for ABX CROSSROADS, facilitating several industry thought leaders through a day long discussion:
Ed Septimus, M.D., FIDSA, FACP, FSHEA, Medical Director Infection Prevention and Epidemiology Clinical Services Group at HCA Healthcare System, will discuss the Crisis of Antimicrobial Resistance and deliver a call to action for healthcare providers worldwide.
Ronald Wyatt, M.D., M.H.A., Medical Director of Healthcare Improvement for The Joint Commission will discuss antibiotics and Patient Safety in the Context of Quality Improvement.
A discussion on Antimicrobial Stewardship in the Age of Pay for Performance and Patient Centered Care will be led by Keith S. Kaye, M.D., M.P.H., FIDSA, FACP, FSHEA, Medical Director of Hospital Epidemiology and Antimicrobial Stewardship Detroit Medical Center and Professor of Medicine at Wayne State University.
Kenneth P. Klinker, PharmD, Clinical Specialist in Infectious Diseases with University of Florida Shands Hospital, will provide financial and operational considerations in his discussion of Quantifying Antimicrobial Stewardship Results for the C-Suite.
Kavita K. Trivedi, M.D., principal and founder of Trivedi Consultants, LLC, will discuss Coordinating Patient Care Beyond the Acute Care Setting.
Senior Vice President of Physician Services and Clinical Integration for Catholic Health Initiatives T. Clifford Deveny, M.D., finishes the day discussing with a challenge for participants to become "Change Agents" of antimicrobial stewardship.
To register for ABX CROSSROADS, or to learn more about the event, visit www.ABXCROSSROADS.com. Become part of the national dialogue on antibiotic resistance by following ABX CROSSROADS on Twitter, LinkedIn, YouTube or Vimeo.
SOURCE ABX CROSSROADS
Also from this source
You just read:
ABX CROSSROADS Advances Discussion, Call to Action Regarding Antibiotic Resistance
Nov 02, 2015, 11:00 EST